Clinical Trial Update: Evaluating Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis [NA]

View source ↗

Summary

A clinical trial evaluating pulmonary arterial hypertension in patients with systemic sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis

Snippet

Sponsor: Echosense Ltd. | Conditions: Systemic Sclerosis, Pulmonary Hypertension | NA | Status: WITHDRAWN